Manish Patel, DO, Associate Professor of Medicine at the University of Minnesota, explains
interventional lung cancer clinical trials, which test
new lung cancer treatments ("
interventions"). He reviews phase 1 through 4 of
clinical trials for lung cancer, from drug safety and effectiveness, to comparing a
trial lung cancer treatment versus the current
lung cancer standard of care. Dr. Patel also explains what happens after a
new treatment developed in a
lung cancer clinical trial is FDA approved.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.